Insight Molecular Diagnostics Inc (IMDX) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Insight Molecular Diagnostics Inc   (NASDAQ: IMDX)
 

Insight Molecular Diagnostics Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Insight Molecular Diagnostics Inc inventory turnover ratio, the Insight Molecular Diagnostics Inc 's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 2.31 in the second quarter 2026, yet the ratio remained below the average, as IMDX's market remain challenging.Average inventory processing period, for the Insight Molecular Diagnostics Inc in Jun 30 2026 quarter, has decreased to 158 days, compare to 190 days, in the Mar 31 2026 quarter.

Within Healthcare sector 170 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1256 in the first quarter 2026, to 1589.

IMDX Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Insight Molecular Diagnostics Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

IMDX Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth -70.13 % -16.78 % 8.78 % 103.02 % -
Y / Y Cost of Sales Growth -51.19 % -97.89 % -25.43 % 181.4 % 425 %
Inventory Turnover Ratio (TTM) 2.31 1.92 3.37 3.86 4.21
IMDX's Total Ranking # 1589 # 1256 # 984 # 693 #
Average inventory processing period 158 191 108 94 87
Seq. Inventory Growth -45.81 % -14.35 % -5.31 % -32.03 % 50.98 %
Seq. Cost of Sales Growth 382.35 % -97.38 % 435.54 % -27.98 % -79.16 %




Inventory Turnover Ratio Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry # 8
Healthcare Sector # 171
Overall Market # 1589

Inventory Turnover Ratio Statistics
High Average Low
4.21 3.13 1.92
(Jun 30 2025)   (Mar 31 2026)



IMDX Company Profile >> Back to IMDX Efficiency Comparisons >> Compare IMDX Inventory Turnover Ratio to its Competitors

Financial Statements
Insight Molecular Diagnostics Inc 's Inventories $ 0 Millions Visit IMDX's Balance sheet
Insight Molecular Diagnostics Inc 's Cost of Revenues TTM $ 1 Millions Visit IMDX's Income Statement
What are IMDX's Sales? Visit IMDX's Sales by Segment

Other Inventory Turnover Ratios
Insight Molecular Diagnostics Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
In Vitro & In Vivo Diagnostic Substances Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
IMDX's Inventory Turnover Ratio versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for IMDX's Competitors
Inventory Turnover Ratio for IMDX's Suppliers
Inventory Turnover Ratio for IMDX's Customers

You may also want to know
IMDX's Sales Growth Rates IMDX's Pe Price to earnings ratio IMDX's Receivables Turnover Ratio IMDX's Stock Quote
IMDX's Net Income Growth Rates IMDX's Ps Price to Sales ratio IMDX's Sales per Employee IMDX's Asset Turnover Ratio
IMDX's Net Margin IMDX's Pb Price to Book ratio IMDX's Financial Strength Ratios IMDX's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Alnylam Pharmaceuticals Inc   11.45 $ 970.735  Millions$ 85  Millions
Infusystem Holdings Inc  10.92 $ 60.985  Millions$ 6  Millions
Irhythm Holdings Inc   10.79 $ 235.967  Millions$ 22  Millions
Genedx Holdings Corp   10.27 $ 140.202  Millions$ 14  Millions
Tarsus Pharmaceuticals Inc   10.20 $ 43.740  Millions$ 4  Millions
Lantheus Holdings Inc   10.09 $ 619.325  Millions$ 61  Millions
Sotera Health Company  10.04 $ 547.412  Millions$ 55  Millions
Natera Inc   9.46 $ 672.186  Millions$ 71  Millions
Warby Parker Inc   9.27 $ 414.054  Millions$ 45  Millions
Hims and Hers Health Inc   9.23 $ 814.411  Millions$ 88  Millions
Polomar Health Services, Inc.  8.80 $ 1.233  Millions$ 0  Millions
Myriad Genetics Inc   8.31 $ 250.700  Millions$ 30  Millions
National Vision Holdings Inc   8.26 $ 841.416  Millions$ 102  Millions
Castle Biosciences Inc   8.14 $ 81.252  Millions$ 10  Millions
Autolus Therapeutics Plc  8.08 $ 99.009  Millions$ 12  Millions
The Oncology Institute Inc   8.03 $ 160.655  Millions$ 20  Millions
Nutriband Inc   7.92 $ 1.082  Millions$ 0  Millions
Novavax inc   7.61 $ 88.541  Millions$ 12  Millions
Inogen Inc   7.51 $ 196.617  Millions$ 26  Millions
Moderna Inc   7.50 $ 1,707.000  Millions$ 228  Millions
Cardiff Lexington Corporation  7.49 $ 4.042  Millions$ 1  Millions
Pulse Biosciences Inc   7.45 $ 1.182  Millions$ 0  Millions
Vanda Pharmaceuticals Inc   7.43 $ 13.506  Millions$ 2  Millions
Carlsmed Inc   7.42 $ 13.955  Millions$ 2  Millions
Adaptive Biotechnologies Corporation  7.26 $ 75.254  Millions$ 10  Millions
Lifemd Inc   7.22 $ 22.284  Millions$ 3  Millions
Phathom Pharmaceuticals Inc   7.01 $ 40.929  Millions$ 6  Millions
Precision Optics Corporation Inc   6.97 $ 26.101  Millions$ 4  Millions
Carlisle Companies Incorporated  6.94 $ 3,299.600  Millions$ 476  Millions
Twist Bioscience Corporation  6.62 $ 207.413  Millions$ 31  Millions

Date modified: 2026-10-05T11:03:41+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.